Aging-related Frailty

Advertisement

cGxPJobs Banner

Longeveron Reports ELPIS II Results for Laromestrocel

MIAMI — September 16, 2026 Longeveron Inc. announced topline results from its Phase 2b ELPIS II clinical trial evaluating...

By cGxPwire Editor
September 17, 2026

Read More

Advertisement

cGxPJobs

Directory